Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sema4
MedTech
Sema4 lays off 448 employees, exits reproductive health testing
Sema4 will shut down its reproductive health testing and services division by early 2023, eliminating about a third of its workforce in the process.
Andrea Park
Nov 18, 2022 10:42am
Sema4 signals $623M bid for genetic testing provider GeneDx
Jan 18, 2022 9:51am
Section 32 closes $740M VC fund to back health tech startups
Nov 4, 2021 10:24am
Sema4 recruits Mount Sinai’s Kasarskis as 1st chief data officer
Jun 17, 2021 12:09pm
Janssen teams up with Sema4 for cancer trial matchmaking service
Sep 29, 2020 9:25am
